Minguito-Carazo et al. studied the effect of SGLT2 inhibitors on ventricular and atrial arrhythmias in patients with implantable cardiac devices, showing a decrease in the percentage of patients with ventricular arrhythmia but no beneficial effect for atrial arrhythmias [22]. Here, SLC5A2 is linked to Ventricular arrhythmia.